Connect with others who understand.

sign up log in
Resources
About MyLymphomaTeam
Powered By

Mesenteric Lymphoma: Your Guide

Posted on July 20, 2021
View reactions
Medically reviewed by
Mark Levin, M.D.
Article written by
Aminah Wali, Ph.D.

Mesenteric lymphoma is a cancer that affects white blood cells called B lymphocytes, or B cells. B cells work as part of the immune system and help the body fight infection. Mesenteric lymphoma is a rare disease, affecting fewer than 1 out of every 200,000 people.

What Is Mesenteric Lymphoma?

The tissue between the intestine and the abdominal wall that envelopes the bowel is called the mesentery. Mesenteric lymphoma forms in the lymph nodes within the mesentery.

Lymphoma is divided into two main categories, Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Mesenteric lymphoma is typically non-Hodgkin lymphoma. Specifically, it is usually a subtype of NHL that forms in B cells, called follicular lymphoma. Some cases are also diffuse large B-cell lymphomas.

Signs and Symptoms of Mesenteric Lymphoma

Signs and symptoms are both indicators of conditions. Symptoms are what a person personally experiences, such as a headache or nausea. Signs are what a doctor can observe or measure, such as a fever or high blood pressure. Abdominal pain is the most common symptom of mesenteric lymphoma, caused by the tumor in the abdomen. In rare cases, a person might also have thrombocytopenia (low levels of platelets in the blood) or dermatitis herpetiformis (a condition that causes itchy skin lesions). Some people with mesenteric lymphoma may not experience any symptoms.

Signs and symptoms that occur with other forms of lymphoma, such as weight loss, may also occur with mesenteric lymphoma.

How Is Mesenteric Lymphoma Diagnosed?

Different medical tests can help a doctor diagnose mesenteric lymphoma.

Imaging Technologies

CT scans, as well as scans using positron emission tomography (PET) combined with CT (PET-CT), are technologies used to image tissues in the body. A CT scan or PET-CT scan can identify an abdominal mass as well as enlarged lymph nodes (lymphadenopathy) or other internal lesions (tumors) caused by mesenteric lymphoma. The primary mass in the mesentery often has a unique appearance referred to as a “sandwich sign” since it resembles a hamburger on the CT scan.

Lymph Node Biopsy

A lymph node biopsy may also be important for diagnosis. In this procedure, a lymph node is surgically removed from the mesentery and examined under a microscope for cancer cells.

Blood Tests

Blood tests can measure blood cell counts and levels of the lactate dehydrogenase (LDH) protein, which may both be affected by lymphoma.

Treatments for Mesenteric Lymphoma

Following diagnosis, the main treatment option for mesenteric lymphoma is surgery to remove the mass, followed by chemotherapy. Chemotherapy may be administered as a single drug, such as bendamustine (Treanda), or as a combination of different drugs. The treatment regimen known as EPOCH has been used to treat mesenteric lymphoma. EPOCH is a combination of:

Chemotherapy is usually given together with a drug called rituximab (Rituxan). Rituximab is an antibody that recognizes a molecule called CD20 on the surface of B cells so it can target the cancer specifically.

Prognosis for Mesenteric Lymphoma

Mesenteric lymphoma is extremely rare, so much of the knowledge around the disease comes from case reports that follow just a single person. As a result, it is difficult to estimate a prognosis (outlook) or survival rate. Some cases indicate that the cancer responds well to chemotherapy. However, it is also possible for the cancer to come back (relapse) after treatment. A person with mesenteric lymphoma should attend follow-up appointments with a doctor to monitor the status of the disease. Additional research needs to be done in order to better understand this rare cancer and identify effective treatments.

Talk With Others Who Understand

MyLymphomaTeam is the social network for people with lymphoma and their loved ones. More than 12,000 members understand what it’s like to face lymphoma and can provide support and answers.

Are you or a loved one newly diagnosed with mesenteric lymphoma? Share your experience in the comments below, or start a conversation by posting on MyLymphomaTeam.

Posted on July 20, 2021
View reactions
All updates must be accompanied by text or a picture.
Mark Levin, M.D. is a hematology and oncology specialist with over 37 years of experience in internal medicine. Review provided by VeriMed Healthcare Network. Learn more about him here.
Aminah Wali, Ph.D. received her doctorate in genetics and molecular biology from the University of North Carolina at Chapel Hill. Learn more about her here.

Related articles

The U.S. Food and Drug Administration (FDA) has approved updated boosters for messenger RNA (mRN...

New COVID-19 Vaccine Boosters for Omicron: What To Know if You Have Lymphoma

The U.S. Food and Drug Administration (FDA) has approved updated boosters for messenger RNA (mRN...
Burkitt lymphoma is a type of non-Hodgkin lymphoma (NHL) that grows very quickly. People who are...

Understanding Treatments for Burkitt Lymphoma

Burkitt lymphoma is a type of non-Hodgkin lymphoma (NHL) that grows very quickly. People who are...
Primary thyroid lymphoma (PTL) is a rare type of cancer. Also called primary lymphoma of the thy...

Understanding Primary Thyroid Lymphoma

Primary thyroid lymphoma (PTL) is a rare type of cancer. Also called primary lymphoma of the thy...
Hepatosplenic T-cell lymphoma (HSTCL) is a type of cancer that affects cells of the immune syste...

What You Need To Know About Hepatosplenic T-cell Lymphoma: Symptoms, Treatment, and Prognosis

Hepatosplenic T-cell lymphoma (HSTCL) is a type of cancer that affects cells of the immune syste...
After being diagnosed with B-cell lymphoma, many people want to better understand their prognosi...

B-Cell Lymphoma Prognosis: Fear, Hope, and Understanding Survival Rates

After being diagnosed with B-cell lymphoma, many people want to better understand their prognosi...
Natural killer (NK)/T-cell lymphoma is a type of non-Hodgkin lymphoma. NK/T-cell lymphoma is als...

Natural Killer/T-Cell Lymphoma: What You Must Know

Natural killer (NK)/T-cell lymphoma is a type of non-Hodgkin lymphoma. NK/T-cell lymphoma is als...

Recent articles

Mantle cell lymphoma (MCL) is a rare type of blood cancer that affects the lymphocytes (white blo...

Mantle Cell Lymphoma Stages: Are Most People Diagnosed at Stage 4?

Mantle cell lymphoma (MCL) is a rare type of blood cancer that affects the lymphocytes (white blo...
Within the first two years of achieving remission after treatment for diffuse large B-cell lympho...

DLBCL Relapse Chances and Treatment Options

Within the first two years of achieving remission after treatment for diffuse large B-cell lympho...
When you’re diagnosed with a cancer such as Waldenstrom’s macroglobulinemia (WM), your head might...

Waldenstrom’s Macroglobulinemia Prognosis: What Is the Survival Rate?

When you’re diagnosed with a cancer such as Waldenstrom’s macroglobulinemia (WM), your head might...
What does your future hold? For people diagnosed with mantle cell lymphoma (MCL) and their loved ...

Mantle Cell Lymphoma Prognosis: What Is the Survival Rate

What does your future hold? For people diagnosed with mantle cell lymphoma (MCL) and their loved ...
Between 30 percent and 40 percent of people with diffuse large B-cell lymphoma (DLBCL) who have a...

DLBCL Relapse: 4 Symptoms To Watch For

Between 30 percent and 40 percent of people with diffuse large B-cell lymphoma (DLBCL) who have a...
When treatment for diffuse large B-cell lymphoma (DLBCL) successfully kills all detectable lympho...

DLBCL Treatment: What Is Complete Response? How Long Does It Last?

When treatment for diffuse large B-cell lymphoma (DLBCL) successfully kills all detectable lympho...
MyLymphomaTeam My lymphoma Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close